The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody
Conrad E.Z. Chan, Shirley G.K. Seah, De Hoe Chye, Shane Massey, Maricela Torres, Angeline P.C. Lim, Steven K.K. Wong, Jacklyn J.Y. Neo, Pui San Wong, Jie Hui Lim, Gary S.L. Loh, Dongling Wang, Jerome D. Boyd-Kirkup, Siyu Guan, Dipti Thakkar, Guo Hui Teo, Kiren Purushotorman, Paul E. Hutchinson, Barnaby E. Young, Jenny G. LowPaul A. MacAry, Hannes Hentze, Venkateshan S. Prativadibhayankara, Kantharaj Ethirajulu, Jason E. Comer, Chien Te K. Tseng, Alan D.T. Barrett, Piers J. Ingram, Trevor Brasel, Brendon John Hanson
Dive into the research topics of 'The Fc-mediated effector functions of a potent SARS-CoV-2 neutralizing antibody, SC31, isolated from an early convalescent COVID-19 patient, are essential for the optimal therapeutic efficacy of the antibody'. Together they form a unique fingerprint.